chr3-111884208-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001134438.2(PHLDB2):c.131C>T(p.Ser44Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000812 in 1,614,162 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000082 ( 1 hom. )
Consequence
PHLDB2
NM_001134438.2 missense
NM_001134438.2 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 3.85
Genes affected
PHLDB2 (HGNC:29573): (pleckstrin homology like domain family B member 2) Enables cadherin binding activity. Involved in several processes, including negative regulation of focal adhesion assembly; regulation of cytoskeleton organization; and regulation of embryonic development. Located in several cellular components, including basal cortex; cell leading edge; and intermediate filament cytoskeleton. Colocalizes with focal adhesion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.02929753).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHLDB2 | NM_001134438.2 | c.131C>T | p.Ser44Phe | missense_variant | 2/18 | ENST00000431670.7 | NP_001127910.1 | |
PHLDB2 | NM_001134439.2 | c.131C>T | p.Ser44Phe | missense_variant | 2/18 | NP_001127911.1 | ||
PHLDB2 | NM_001134437.2 | c.212C>T | p.Ser71Phe | missense_variant | 3/18 | NP_001127909.1 | ||
PHLDB2 | NM_145753.2 | c.131C>T | p.Ser44Phe | missense_variant | 2/17 | NP_665696.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHLDB2 | ENST00000431670.7 | c.131C>T | p.Ser44Phe | missense_variant | 2/18 | 1 | NM_001134438.2 | ENSP00000405405.2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152176Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
12
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251088Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135684
GnomAD3 exomes
AF:
AC:
37
AN:
251088
Hom.:
AF XY:
AC XY:
28
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461868Hom.: 1 Cov.: 32 AF XY: 0.000117 AC XY: 85AN XY: 727238
GnomAD4 exome
AF:
AC:
120
AN:
1461868
Hom.:
Cov.:
32
AF XY:
AC XY:
85
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74462
GnomAD4 genome
AF:
AC:
11
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
19
Asia WGS
AF:
AC:
5
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.131C>T (p.S44F) alteration is located in exon 2 (coding exon 1) of the PHLDB2 gene. This alteration results from a C to T substitution at nucleotide position 131, causing the serine (S) at amino acid position 44 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D;D;D;D;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;M;M;.;.;.;M;M
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D
REVEL
Benign
Sift
Uncertain
D;D;D;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D
Polyphen
B;B;B;.;B;D;B;B
Vest4
MutPred
0.17
.;Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);Gain of glycosylation at S45 (P = 0.0041);
MVP
MPC
0.10
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at